“$26 Billion Agreement with Opioid Distributors/Manufacturer
On July 21, 2021, a bipartisan coalition of attorneys general announced final agreements with Johnson & Johnson, a manufacturer of prescription opioids, and the three major pharmaceutical distributors — Amerisource Bergen, Cardinal Health, and McKesson.”
Yes. But my question remains, why not regulate this at the prescription level? When certain pharmacies in West Virginia were dispensing Oxycontin at levels that far exceeded the entire population of their area, that was a pretty damn good signal to have a good look into prescribing practices.